Operating Lease, Right-of-Use Asset of Encompass Health Corp from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Encompass Health Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Encompass Health Corp Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $212,600,000, a 4.4% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Encompass Health Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $212,600,000 +$8,900,000 +4.4% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $218,100,000 +$8,400,000 +4% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $215,500,000 -$800,000 -0.37% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $218,700,000 +$19,600,000 +9.8% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $203,700,000 -$4,800,000 -2.3% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $209,700,000 +$12,900,000 +6.6% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $216,300,000 +$10,100,000 +4.9% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $199,100,000 -$13,600,000 -6.4% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $208,500,000 -$4,000,000 -1.9% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $196,800,000 +$1,100,000 +0.56% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $206,200,000 -$32,300,000 -14% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $212,700,000 -$24,100,000 -10% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $212,500,000 +$18,800,000 +9.7% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $195,700,000 -$43,300,000 -18% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $238,500,000 -$6,400,000 -2.6% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $236,800,000 -$11,500,000 -4.6% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $193,700,000 -$52,000,000 -21% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $239,000,000 -$28,200,000 -11% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $244,900,000 -$23,600,000 -8.8% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $248,300,000 -$19,600,000 -7.3% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $245,700,000 -$30,800,000 -11% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $267,200,000 -$44,200,000 -14% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $268,500,000 -$15,900,000 -5.6% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $267,900,000 -$17,000,000 -6% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $276,500,000 +$276,500,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $311,400,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $284,400,000 30 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $284,900,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 31 Oct 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.